Target
Epidermal growth factor receptor [696-1022,L858R]
Ligand
BDBM50289149
Substrate
n/a
Meas. Tech.
Kinase Hotspot Assay
IC50
2.58±n/a nM
Citation
 Mahmoud, GEChoi, HSYoo, KHHan, DKOh, CHMohammed, AMohammed, IEAmmar, UM Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same US Patent  US11332479 Publication Date 5/17/2022 
Target
Name:
Epidermal growth factor receptor [696-1022,L858R]
Synonyms:
EGF-R Tyrosine Kinase Mutant (L858R) | EGFR | EGFR_HUMAN | ERBB | ERBB1 | Epidermal growth factor receptor [696-1022,L858R] | HER1 | c-raf
Type:
Tyrosine-protein kinase
Mol. Mass.:
37296.75
Organism:
Homo sapiens (Human)
Description:
P00533[696-1022,L858R]
Residue:
327
Sequence:
GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG
  
Inhibitor
Name:
BDBM50289149
Synonyms:
GW305074X | GW5074 | US10570155, GW5074 | US11332479, Compound GW5074
Type:
Small organic molecule
Emp. Form.:
C15H8Br2INO2
Mol. Mass.:
520.942
SMILES:
Oc1c(Br)cc(C=C2C(=O)Nc3ccc(I)cc23)cc1Br
Structure:
Search PDB for entries with ligand similarity: